UK markets closed

e-Therapeutics plc (ETX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
9.80+0.20 (+2.08%)
At close: 04:35PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 57.26M
Enterprise value 32.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)163.75
Price/book (mrq)2.08
Enterprise value/revenue 95.62
Enterprise value/EBITDA -2.86

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-14.97%
S&P500 52-week change 322.36%
52-week high 324.00
52-week low 38.00
50-day moving average 312.23
200-day moving average 312.81

Share statistics

Avg vol (3-month) 3734.75k
Avg vol (10-day) 31.93M
Shares outstanding 5584.33M
Implied shares outstanding 6584.33M
Float 8245.64M
% held by insiders 159.44%
% held by institutions 126.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Jan 2023
Most-recent quarter (mrq)31 Jul 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,356.25%

Management effectiveness

Return on assets (ttm)-29.10%
Return on equity (ttm)-38.75%

Income statement

Revenue (ttm)340k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-45.80%
Gross profit (ttm)N/A
EBITDA -12.56M
Net income avi to common (ttm)-10.06M
Diluted EPS (ttm)-0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.84M
Total cash per share (mrq)0.04
Total debt (mrq)90k
Total debt/equity (mrq)0.33%
Current ratio (mrq)22.20
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-10.15M
Levered free cash flow (ttm)-7.64M